Key result
Acarbose, linagliptin, and quercetin equally improve aortic histology in type 2 diabetic rats.
Why the study?
Diabetes causes deleterious vascular effects, and the study aimed to compare the potential protective effects of acarbose, linagliptin, and quercetin on the aorta in a type 2 diabetic rat model.
Do Acarbose, Linagliptin, or Quercetin ameliorate histological changes in the aorta of a type 2 diabetic rat model?
Do Acarbose, Linagliptin, or Quercetin ameliorate histological changes in the aorta of a type 2 diabetic rat model?
Acarbose, Linagliptin, and Quercetin similarly ameliorate structural changes in the aorta of a type 2 diabetic rat model.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for aortic protection in diabetic models; should not yet change clinical practice.
Background: Diabetes mellitus (DM) is a worldwide health problem affecting a population of different ages, which inflicts a large economic load on the worldwide health-care system. This disease is mostly characterized by hyperglycemia which causes deleterious effects on both the macro- and microvasculature. Pharmacological treatment includes many drugs with different mechanisms of action. These drugs aim to control the hyperglycemic state and subsequently may protect the vessels from its deleterious effect.Aim of the Work: The aim of our study is to compare the potential protective effect of three of these antidiabetic drugs; Acarbose, Linagliptin and Quercetin, on the aorta of type 2 diabetes mellitus rat model.Materials and Methods: Forty male albino rats were divided into 5 groups. Two control groups; normal control group (normal group) and diabetic control group (DM group). Diabetes was induced by feeding rats with high-fat diet (HFD) for 2 weeks followed by a single dose Streptozotocin (STZ) injection. Three diabetic groups received different treatments; diabetic group treated with Acarbose (DM+AC group), diabetic group treated with Linagliptin (DM+LN group) and diabetic group treated with Quercetin (DM+QR group). Blood samples were taken for biochemical evaluation and specimens of the aorta were taken for histological and morphometric analysis.Results: Diabetic group showed histological findings recorded in atherosclerotic aorta. The three tested antidiabetic drugs Acarbose, Linagliptin and Quercetin, showed an ameliorative effect on the structure of the aorta but no noticeable differences were recorded.Conclusion: Our study revealed that the changes produced in the structure of the aorta of the diabetic group were ameliorated in the groups received the three drugs with no noticeable differences between them.
No takes yet. Share an insight, caveat, or question.
Kandiel et al. (2021) studied Type 2 diabetes mellitus (n=40). Acarbose, Linagliptin, and Quercetin vs. Diabetic control group and normal control group was evaluated on Histological and morphometric changes in the aorta. Acarbose, Linagliptin, and Quercetin ameliorated the histological changes in the aorta of type 2 diabetic rats with no noticeable differences between the three drugs.
Synapse has enriched 10 related papers. Consider them for comparative context: